阻塞性睡眠呼吸暂停低通气综合征治疗对难治性高血压患者血压的影响
80例OSAHS合并难治性高血压患者接受手术或持续正压通气治疗,治疗6个月后AHI由(32.9±10.8)次/h降至(9.4±6.5)次/h,最低SaO₂由(0.682±0.062)增至(0.884±0.056),全天、日间及夜间血压均下降,夜间血压下降幅度大于日间,降压药物种类由(3.2±0.4)种减为(2.6±0.5)种。
要点
- OSAHS合并难治性高血压患者治疗6个月后AHI与最低SaO₂均显著改善(P<0.001)。
- 治疗后全天、日间及夜间收缩压与舒张压均显著下降(P<0.001)。
- 夜间血压下降幅度大于日间,降压药物种类由(3.2±0.4)种减为(2.6±0.5)种。
核心结论
- OSAHS合并RH患者经手术或持续正压通气治疗6个月后血压显著下降,血压昼夜节律改善,降压药物种类减少。
研究设计与样本
- 80例OSAHS合并RH患者(至少3种抗高血压药包括利尿剂治疗仍不能将血压控制在140/90 mmHg以下)行手术或持续正压通气治疗,治疗前及治疗6个月后行多道睡眠监测和动态血压监测。
主要发现
- AHI由治疗前(32.9±10.8)次/h降至治疗后(9.4±6.5)次/h,最低SaO₂由(0.682±0.062)增至(0.884±0.056),差异均有统计学意义(t值分别为18.863、26.614,P值均<0.001)。
- 全天收缩压由(150.5±9.8) mmHg降至(140.7±6.8) mmHg,舒张压由(97.8±7.3) mmHg降至(88.6±6.3) mmHg;日间收缩压由(154.3±8.9) mmHg降至(144.8±5.8) mmHg,舒张压由(100.6±7.4) mmHg降至(91.3±5.5) mmHg;夜间收缩压由(145.5±8.8) mmHg降至(135.8±5.7) mmHg,舒张压由(93.8±6.4) mmHg降至(84.6±5.9) mmHg,差异均有统计学意义(t值分别为7.832、6.903、7.005、6.848、8.025、7.554,P值均<0.001)。
- 夜间收缩压下降值为(11.5±2.2) mmHg、舒张压下降值为(10.2±3.1) mmHg,日间收缩压下降值为(9.0±2.8) mmHg、舒张压下降值为(7.9±3.5) mmHg,夜间收缩压及舒张压下降较日间更明显,差异均有统计学意义(t值分别为9.732、6.936,P值均<0.001)。
- 夜间血压下降率<10%的患者比例由治疗前的75.0%降为治疗后的37.5%,差异有统计学意义(χ²=22.857,P<0.01)。
- 45例(56.3%)患者服用的降压药物种类减少,平均种类由治疗前(3.2±0.4)种减为治疗后(2.6±0.5)种,差异有统计学意义(t=9.276,P<0.01)。
临床怎么用
- 原文结论为OSAHS合并RH患者治疗OSAHS能有效改善血压控制水平、改善血压昼夜节律、减少降压药物的使用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the effect of the treatments for obstructive sleep apnea hypopnea syndrome (OSAHS) on the resistant hypertension (RH) of patients. Methods: Eighty patients with OSAHS and RH (blood pressure could not be controlled under 140/90 mmHg (1 mmHg=0.133 kPa) even with more than three kinds of antihypertensive drugs including diuretics) received surgery or continuous positive airway pressure (CPAP) treatment. The results of polysomnography monitoring, ambulatory blood pressure monitoring, and the dosage of antihypertensive medication were recorded before and six months after the treatment. Results: Apnea hypopnea index (AHI) decreased from (32.9±10.8) before treatment to (9.4±6.5) after treatment, while the lowest oxygen saturation (SaO(2)) increased from (0.682±0.062) to (0.884±0.056), with significant differences (t value was 18.863 and 26.614, respectively; both P<0.001). Twenty-four hours systolic blood pressure (SBP)/diastolic blood pressure (DBP) decreased respectively from ((150.5±9.8)/(97.8±7.3)) mmHg to ((140.7±6.8)/(88.6±6.3)) mmHg, daytime SBP/DBP decreased from ((154.3±8.9)/(100.6±7.4)) mmHg to ((144.8±5.8)/(91.3±5.5)) mmHg, and nighttime SBP/DBP decreased from ((145.5±8.8)/(93.8±6.4)) mmHg to ((135.8±5.7)/(84.6±5.9)) mmHg, with significant differences (t value was 7.832, 6.903, 7.005, 6.848, 8.025, 7.554, respectively; all P<0.001). The reduction of nighttime SBP /DBP was ((11.5±2.2)/(10.2±3.1)) mmHg, and the reduction of daytime SBP/DBP was ((9.0±2.8)/(7.9±3.5)) mmHg. The reduction of nighttime SBP/DBP was more obvious than daytime SBP/DBP, with significant differences (t value was 9.732 and 6.936, respectively; both P<0.001). Before treatment, nighttime blood pressure decrease rate below 10% was showed in 75 percent of patients, and after treatment, this rate only in 37.5 percent of patients (χ(2)=22.857, P<0.01). The numbers of required antihypertensive drugs decreased in 45 (56.3%) cases, the average numbers of antihypertensive drugs decreased from (3.2±0.4) before treatment to (2.6±0.5) after treatment, with a significant difference (t=9.276, P<0.01). Conclusions: After treatment of OSAHS, the blood pressure of the patients with OSAHS and RH dropped significantly, the circadian rhythm of blood pressure condition was better, the varieties of antihypertensive drugs taken in these patients were reduced significantly. 目的: 研究阻塞性睡眠呼吸暂停低通气综合征(obstructive sleep apnea hypopnea syndrome,OSAHS)合并难治性高血压(resistant hypertension,RH)患者中,OSAHS的治疗对血压控制的意义。 方法: 80例OSAHS合并RH患者[至少3种抗高血压药(包括利尿剂)治疗,仍不能将收缩压和舒张压控制在目标水平(140/90 mmHg, 1 mmHg=0.133 kPa)]行手术或持续正压通气治疗,治疗前及治疗6个月后行多道睡眠监测和动态血压监测,记录呼吸暂停低通气指数(apnea hypopnea index,AHI)、最低血氧饱和度(SaO(2))、血压、夜间血压下降率,比较治疗前后降压药物种类的变化。 结果: 治疗后,AHI由(32.9±10.8)次/h(x±s,下同)降至(9.4±6.5)次/h,最低SaO(2)由(0.682±0.062)增至(0.884±0.056),差异均有统计学意义(t值分别为18.863、26.614,P值均<0.001)。全天收缩压由(150.5±9.8) mmHg降至(140.7±6.8) mmHg,舒张压由(97.8±7.3) mmHg降至(88.6±6.3) mmHg;日间收缩压由(154.3±8.9) mmHg降至(144.8±5.8) mmHg,舒张压由(100.6±7.4) mmHg降至(91.3±5.5) mmHg;夜间收缩压由(145.5±8.8) mmHg降至(135.8±5.7) mmHg,舒张压由(93.8±6.4) mmHg降至(84.6±5.9) mmHg,差异均有统计学意义(t值分别为7.832、6.903、7.005、6.848、8.025、7.554,P值均<0.001)。夜间收缩压下降值为(11.5±2.2)mmHg、舒张压下降值为(10.2±3.1)mmHg,日间收缩压下降值为(9.0±2.8)mmHg、舒张压下降值为(7.9±3.5)mmHg,夜间收缩压及舒张压下降较日间更明显,差异均有统计学意义(t值分别为9.732、6.936,P值均<0.001)。夜间血压下降率<10%的患者比例由治疗前的75.0%降为治疗后的37.5%,差异有统计学意义(χ(2)=22.857,P<0.01),提示血压昼夜节律变化情况好转。45例患者服用的降压药物种类减少,由治疗前的(3.2±0.4)种减为治疗后的(2.6±0.5)种,差异有统计学意义(t=9.276,P<0.01)。 结论: OSAHS合并RH患者中,治疗OSAHS能有效改善血压控制水平,改善血压昼夜节律,减少降压药物的使用。.
引用
- Wang HW, Liu HM, Zheng ZY, et al. [Effect of the obstructive sleep apnea hypopnea syndrome treatment on blood pressure in patients with resistant hypertension]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017. PMID: 28104016. doi:10.3760/cma.j.issn.1673-0860.2017.01.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。